RTW Biotech Opportunities (LON:RTW) Shares Up 1.4% – What’s Next?

RTW Biotech Opportunities (LON:RTW)’s share price shot up 1.4% during trading on Monday . The company traded as high as GBX 2.22 and last traded at GBX 2.19. 43,931 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 608,552 shares. The stock had previously closed at GBX 2.16.

RTW Biotech Opportunities Trading Up 1.4%

The firm has a market capitalization of £7.15 million, a price-to-earnings ratio of -0.08 and a beta of 0.60. The firm has a 50 day moving average price of GBX 1.92 and a two-hundred day moving average price of GBX 1.57.

About RTW Biotech Opportunities

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.